Druggable glycolytic requirement for Hedgehog-dependent neuronal and medulloblastoma growth

Aberrant activation of SHH pathway is a major cause of medulloblastoma (MB), the most frequent brain malignancy of the childhood. A few Hedgehog inhibitors, all antagonizing the membrane transducer Smo, have been approved or are under clinical trials for the treatment of human MB. However, the effic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Cycle
Autors principals: Di Magno, Laura, Manzi, Daniela, D’Amico, Davide, Coni, Sonia, Macone, Alberto, Infante, Paola, Di Marcotullio, Lucia, De Smaele, Enrico, Ferretti, Elisabetta, Screpanti, Isabella, Agostinelli, Enzo, Gulino, Alberto, Canettieri, Gianluca
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2014
Matèries:
Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4613849/
https://ncbi.nlm.nih.gov/pubmed/25485584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/15384101.2014.952973
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars